Metabolic Acidosis clinical trials at UC Davis
2 research studies open to eligible people
Veverimer for the Treatment of Metabolic Acidosis
open to eligible people ages 18 years and up
The purpose of this 26 week study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.
Sacramento, California and other locations
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 21-85
Skeletal muscle metabolic health is critical for mobility and an underrecognized target of metabolic acidosis in chronic kidney disease. Impaired muscle mitochondrial metabolism underlies poor physical endurance increasing the risk of mobility disability. The proposed project will use precise in vivo tools to study the pathophysiology of poor physical endurance in a clinical trial treating metabolic acidosis among persons living with chronic kidney disease.
Sacramento, California and other locations
Our lead scientists for Metabolic Acidosis research studies include Baback Roshanravan, MD.
Last updated: